BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18097600)

  • 1. A peptide derived from alpha-fetoprotein inhibits the proliferation induced by estradiol in mammary tumor cells in culture.
    Sierralta WD; Epuñan MJ; Reyes JM; Valladares LE; Andersen TT; Bennett JA; Jacobson HI; Pino AM
    Oncol Rep; 2008 Jan; 19(1):229-35. PubMed ID: 18097600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A synthetic peptide derived from alpha-fetoprotein inhibits the estradiol-induced proliferation of mammary tumor cells in culture through the modulation of p21.
    Sierralta WD; Epuñan MJ; Reyes JM; Valladares LE; Pino AM
    Adv Exp Med Biol; 2008; 617():463-8. PubMed ID: 18497070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antrodia camphorata inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Hseu YC; Chen SC; Chen HC; Liao JW; Yang HL
    Food Chem Toxicol; 2008 Aug; 46(8):2680-8. PubMed ID: 18550246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cyclic peptide derived from alpha-fetoprotein inhibits the proliferative effects of the epidermal growth factor and estradiol in MCF7 cells.
    Torres C; Antileo E; Epuñán MJ; Pino AM; Valladares LE; Sierralta WD
    Oncol Rep; 2008 Jun; 19(6):1597-603. PubMed ID: 18497971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
    Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
    Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein.
    Joseph LC; Bennett JA; Kirschner KN; Shields GC; Hughes J; Lostritto N; Jacobson HI; Andersen TT
    J Pept Sci; 2009 Apr; 15(4):319-25. PubMed ID: 19189271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
    Bennett JA; Zhu S; Pagano-Mirarchi A; Kellom TA; Jacobson HI
    Clin Cancer Res; 1998 Nov; 4(11):2877-84. PubMed ID: 9829755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tetramethoxystilbene on hormone-resistant breast cancer cells: biological and biochemical mechanisms of action.
    Park H; Aiyar SE; Fan P; Wang J; Yue W; Okouneva T; Cox C; Jordan MA; Demers L; Cho H; Kim S; Song RX; Santen RJ
    Cancer Res; 2007 Jun; 67(12):5717-26. PubMed ID: 17575138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein.
    Caceres G; Dauphinee MJ; Eisele LE; MacColl R; Mizejewski GJ
    Anticancer Res; 2002; 22(5):2817-20. PubMed ID: 12530002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture.
    van Meeuwen JA; Korthagen N; de Jong PC; Piersma AH; van den Berg M
    Toxicol Appl Pharmacol; 2007 Jun; 221(3):372-83. PubMed ID: 17482226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
    Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
    Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
    Ji YB; Zhou JH; Zuo MX; You QD
    Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cyclized peptide derived from alpha fetoprotein inhibits the proliferation of ER-positive canine mammary cancer cells.
    Torres CG; Pino AM; Sierralta WD
    Oncol Rep; 2009 Jun; 21(6):1397-404. PubMed ID: 19424616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells.
    Ahn MY; Lee J; Na YJ; Choi WS; Lee BM; Kang KW; Kim HS
    Chem Biol Interact; 2009 May; 179(2-3):169-77. PubMed ID: 19070610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R; Hanf V; Emons G; Gründker C
    J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique.
    Foster PA; Ho YT; Newman SP; Kasprzyk PG; Leese MP; Potter BV; Reed MJ; Purohit A
    Breast Cancer Res Treat; 2008 Sep; 111(2):251-60. PubMed ID: 17957467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xanthohumol inhibits inflammatory factor production and angiogenesis in breast cancer xenografts.
    Monteiro R; Calhau C; Silva AO; Pinheiro-Silva S; Guerreiro S; Gärtner F; Azevedo I; Soares R
    J Cell Biochem; 2008 Aug; 104(5):1699-707. PubMed ID: 18348194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells.
    Rajah TT; Du N; Drews N; Cohn R
    Pharmacology; 2009; 84(2):68-73. PubMed ID: 19556829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells.
    Su Q; Hu S; Gao H; Ma R; Yang Q; Pan Z; Wang T; Li F
    Oncology; 2008; 75(3-4):159-68. PubMed ID: 18827493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.